The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
We count down the top five things that everybody should know about HIV - from AIDS, to testing, to symptoms, to treatment.
Viral load testing could become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.
Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.
Heightened concerns regarding the link between the hormonal contraceptive, Depo-Provera, and the risk of HIV acquisition in women after new systematic review released.
AVERT Chief Executive, Sarah Hand, reflects on the biannual International AIDS Conference (AIDS 2016) in Durban, and where we should focus our efforts for an effective HIV response going forward.
A bold new framework, part of the ‘Start Free, Stay Free, AIDS Free’ initiative, was launched at AIDS 2016 with the aim of ending AIDS among children, adolescents and young women by 2020.
